Literature DB >> 2106560

The temporal order of appearance of transcripts from unrearranged and rearranged Ig genes in murine fetal liver.

G G Lennon1, R P Perry.   

Abstract

The developmental time course of RNA transcribed from unrearranged (germ-line) and rearranged Ig genes in murine fetal liver was determined by a quantitative Northern blot analysis. Sterile Cmu transcripts and germ-line VH transcripts are detectable as early as day 14, whereas significant amounts of rearranged VDJCmu H chain transcripts do not appear until days 16 to 17. The sterile Cmu transcripts continuously increase in abundance throughout fetal development, in contrast to the germ-line VH transcripts, which decrease abruptly after day 16. Transcripts of germ-line and rearranged CK genes are detectable on day 17, and continue to increase in abundance on day 18. Transcripts from a pre-B cell specific gene, lambda 5, first appear on day 15, and reach maximum abundance on day 17. The order of these events is consistent with the known order of gene rearrangements and with the idea that transcriptional activation of germ-line loci is a prerequisite for Ig gene rearrangement. The lag between the onsets of germ-line Cmu and VH transcription and the appearance of VDJCmu transcripts suggests that additional developmentally regulated events may be necessary to achieve efficient expression of completely rearranged H chain genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106560

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Regulation of V(D)J recombination by transcriptional promoters.

Authors:  M L Sikes; C C Suarez; E M Oltz
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Ectopic recombination within homologous immunoglobulin mu gene constant regions in a mouse hybridoma cell line.

Authors:  M D Baker; L R Read
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

3.  Fetal liver pro-B and pre-B lymphocyte clones: expression of lymphoid-specific genes, surface markers, growth requirements, colonization of the bone marrow, and generation of B lymphocytes in vivo and in vitro.

Authors:  R Palacios; J Samaridis
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

4.  Transcription of germ line V alpha segments correlates with ongoing T-cell receptor alpha-chain rearrangement.

Authors:  J D Fondell; K B Marcu
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

5.  Gene and genon concept: coding versus regulation. A conceptual and information-theoretic analysis of genetic storage and expression in the light of modern molecular biology.

Authors:  Klaus Scherrer; Jürgen Jost
Journal:  Theory Biosci       Date:  2007-09-22       Impact factor: 1.919

6.  Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

Authors:  C L Miller; A L Feldhaus; J W Rooney; L D Rhodes; C H Sibley; H Singh
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

7.  Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment.

Authors:  C Angelin-Duclos; K Calame
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

Review 8.  The center of accessibility: Dβ control of V(D)J recombination.

Authors:  Michael L Sikes; Ruth E McMillan; Justin M Bradshaw
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-10-02       Impact factor: 4.291

9.  Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation.

Authors:  D P O'Brien; E M Oltz; B G Van Ness
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

10.  Transcription of productive and nonproductive VDJ-recombined alleles after IgH allelic exclusion.

Authors:  Janssen Daly; Steve Licence; Aikaterini Nanou; Geoff Morgan; Inga-Lill Mårtensson
Journal:  EMBO J       Date:  2007-09-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.